Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
21.33
+0.13 (0.61%)
At close: Mar 9, 2026, 4:00 PM EDT
21.31
-0.02 (-0.09%)
After-hours: Mar 9, 2026, 6:46 PM EDT

DAWN Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Market Capitalization
2,2039571,2781,2711,5831,044
Upgrade
Market Cap Growth
78.65%-25.11%0.54%-19.71%51.68%-
Upgrade
Enterprise Value
1,7625087228661,209747
Upgrade
Last Close Price
21.209.3212.6714.6021.5216.85
Upgrade
PS Ratio
13.916.059.74---
Upgrade
PB Ratio
4.952.172.543.674.773.71
Upgrade
P/TBV Ratio
5.202.262.623.674.773.71
Upgrade
EV/Sales Ratio
11.143.215.50---
Upgrade
Debt / Equity Ratio
0.010.010.010.000.000.00
Upgrade
Net Debt / Equity Ratio
-0.99-0.99-1.05-1.06-1.03-1.01
Upgrade
Net Debt / EBITDA Ratio
3.533.532.511.782.333.91
Upgrade
Net Debt / FCF Ratio
4.214.216.592.493.115.85
Upgrade
Asset Turnover
0.290.290.27---
Upgrade
Inventory Turnover
3.573.57----
Upgrade
Quick Ratio
7.737.737.4312.4220.6032.84
Upgrade
Current Ratio
8.028.027.6612.7220.9433.43
Upgrade
Return on Equity (ROE)
-22.74%-22.74%-22.49%-55.68%-46.37%-44.83%
Upgrade
Return on Assets (ROA)
-14.64%-14.64%-27.67%-35.52%-28.74%-27.10%
Upgrade
Return on Capital Employed (ROCE)
-28.60%-28.60%-41.70%-59.50%-44.20%-25.90%
Upgrade
Earnings Yield
-4.88%-11.21%-7.47%-14.87%-8.98%-6.77%
Upgrade
FCF Yield
-4.73%-10.88%-6.28%-11.57%-6.94%-4.65%
Upgrade
Buyback Yield / Dilution
-10.70%-10.70%-16.87%-21.85%-77.13%-568.42%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.